All In Biotech

Drug Trial Radar · NCT00252291

Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics

A Phase III Multicenter Study to Demonstrate the Sensitivity and Specificity of Aridol (Mannitol) Challenge to Predict Bronchial Hyperresponsiveness as Manifested by a Positive Exercise Challenge in Subjects Presenting With Signs and Symptoms Suggestive of Asthma But Without a Definitive Diagnosis

Last checked: Nov 20, 2026Latest source record: Dec 1, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 240 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

240

Actual

Start

Nov 2005

Primary completion

Not stated

Study completion Sep 2006

Sponsor

Lead sponsor
SyntaraIndustry
Sponsor type
Industry
First posted
Nov 11, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Crossover
Masking
Single
Primary purpose
Diagnostic
Who can join
All sexes, from 6 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3 study to determine the sensitivity and specificity of the Aridol bronchial challenge test to detect bronchial hyperresponsiveness in patients with suspected asthma. Patients with suspected asthma of either gender, aged between 6 and 50 years, with only mildly impaired lung function (FEV1 \>70%) are to be tested with three different bronchial hyperresponsiveness challenges (Aridol, exercise and methacholine), and the results compared. A clinical diagnosis will also be made at the end of the study.

Conditions

  • Asthma

Interventions

  • AridolDrug

  • MethacholineDrug

  • Exercise challengeProcedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Comparison of Aridol and exercise BHR tests
  2. Safety of Aridol test

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Colorado Asthma and Allergy Centers, 125 Rampart Way

    Denver, Colorado

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.